CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 468308-468507 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T22079","span":{"begin":0,"end":199},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In several studies, the investigational, oral, once-daily PDE4 inhibitor roflumilast has provided clinically meaningful improvements in patients with chronic obstructive pulmonary disease and asthma."}

{"project":"Epistemic_Statements","denotations":[{"id":"T834","span":{"begin":0,"end":199},"obj":"Epistemic_statement"}],"text":"In several studies, the investigational, oral, once-daily PDE4 inhibitor roflumilast has provided clinically meaningful improvements in patients with chronic obstructive pulmonary disease and asthma."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T194","span":{"begin":0,"end":199},"obj":"Sentence"}],"text":"In several studies, the investigational, oral, once-daily PDE4 inhibitor roflumilast has provided clinically meaningful improvements in patients with chronic obstructive pulmonary disease and asthma."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T4623","span":{"begin":150,"end":187},"obj":"Disease"},{"id":"T4624","span":{"begin":170,"end":187},"obj":"Disease"},{"id":"T4625","span":{"begin":192,"end":198},"obj":"Disease"}],"attributes":[{"id":"A4623","pred":"mondo_id","subj":"T4623","obj":"http://purl.obolibrary.org/obo/MONDO_0005002"},{"id":"A4624","pred":"mondo_id","subj":"T4624","obj":"http://purl.obolibrary.org/obo/MONDO_0005275"},{"id":"A4625","pred":"mondo_id","subj":"T4625","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"}],"text":"In several studies, the investigational, oral, once-daily PDE4 inhibitor roflumilast has provided clinically meaningful improvements in patients with chronic obstructive pulmonary disease and asthma."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T2548","span":{"begin":150,"end":187},"obj":"Phenotype"},{"id":"T2549","span":{"begin":192,"end":198},"obj":"Phenotype"}],"attributes":[{"id":"A2548","pred":"hp_id","subj":"T2548","obj":"http://purl.obolibrary.org/obo/HP_0006510"},{"id":"A2549","pred":"hp_id","subj":"T2549","obj":"http://purl.obolibrary.org/obo/HP_0002099"}],"text":"In several studies, the investigational, oral, once-daily PDE4 inhibitor roflumilast has provided clinically meaningful improvements in patients with chronic obstructive pulmonary disease and asthma."}